Drugs / Compound cantharides capsule
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT07309419 | Dec 2025 → Jun 2030 expected | hepatocellular carcinoma | Shanghai Zhongshan Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Compound cantharides capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07309419 ↗ |
| Route | Oral | “Compound cantharides capsule: 750mg, PO, tid” NCT07309419 ↗ |